Callan Capital »

Biogen Idec shares owned by Callan Capital

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Callan Capital from 13F filings

Historical chart of Callan Capital investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Callan Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Callan Capital

Quarter filed Position value Share count Share price at filing
2013-03-31 $1.2M 5.4k 218.98
2012-12-31 $793k 5.4k 146.42

More positions owned by Callan Capital

Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Meta Platforms Cl A (META)
Schwab Strategic Tr Fundamental Us L (FNDX)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Schwab Strategic Tr Fundamental Intl (FNDF)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Invesco Exchange Traded Fd T Ftse Rafi 1000 (PRF)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
NVIDIA Corporation (NVDA)
Schwab Strategic Tr Fundamental Us B (FNDB)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Apple (AAPL)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Goldman Sachs Etf Tr Activebeta Int (GSIE)

View all positions for Callan Capital

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
BlackRock
State Street Corporation
Jpmorgan Chase & Co
T. Rowe Price Investment Management
Geode Capital Management
T. Rowe Price Associates
Beutel, Goodman & Company
Invesco
Morgan Stanley
Goldman Sachs Group
Northern Trust
RA Capital Management

View all funds holding Biogen Idec